LETYBO
LIVE

Serial Number

79266012

Owner

HUGEL INC.

Attorney

James R Menker

Filing Date

Jun 13, 2019

Add to watchlist:

No watchlists yet
View on USPTO

LETYBO Trademark

Serial Number: 79266012 • Registration: 6181983

LETYBO is a trademark filed by HUGEL INC. on June 13, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

HUGEL INC. (23 trademarks)

23, Geodudanji 1-gil, Dongnae- myeon,

Entity Type: 03

Trademark Details

Filing Date

June 13, 2019

Registration Date

October 27, 2020

Published for Opposition

August 11, 2020

Goods & Services

Pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for treating dystonia; muscle relaxants; pharmaceutical products for skin care for animals; pharmaceutical preparations used in cosmetic surgery; pharmaceutical preparations containing botulinum toxin; botulinum toxin for medical use for use in the treatment of neuropathy pain; pharmaceutical preparations containing botulinum toxin for the treatment of wrinkles; pharmaceutical preparations containing botulinum toxin fragments for the treatment of wrinkles; pharmaceutical preparations for use in treating urogenital system diseases and conditions, namely, overactive bladder and urinary incontinence; bacterial toxins, namely, bacterial poisons; pharmaceutical preparations for digestive system; pharmacological preparations for skin care; pharmaceutical preparations for treating peripheral neurological diseases and disorders; pharmaceutical preparations for treating central neurological diseases and disorders; ophthalmic preparations for use in the treatment of blepharospasm and strabismus; medicated ointments for treating dermatological conditions; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical agents for epidermis; drugs for medical purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; drugs for medical purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; drugs for medical purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; biological preparations for medical or veterinary purposes for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; cultures of microorganisms for medical or veterinary use; chemical reagents for medical or veterinary purposes; bacteriological preparations for medical and veterinary use; adjuvants for medical purposes; hyaluronic acid preparations for medical purposes; medicines for human purpose, namely, medicines for skin care; pharmaceutical preparations for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for the treatment of orthopaedic disorders, namely, hip dislocation, spinal column deformation, curvature of the spine, namely, scoliosis, lordosis, cyphosis; pharmaceutical preparations for smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, tremors and pain; pharmaceutical preparations for the treatment of wrinkles; injectable dermal filler; medicines for dental purposes; preparation for the relief of pain; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations mainly based on hyaluronic acid for treatments, namely, injectable for intradermal and subcutaneous application for facial and body skin tightening and smoothing; botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders; therapeutic drugs and agents for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 27, 2025 REM3
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 29, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 13, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 13, 2025 OPNR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 21, 2025 ADCH
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 5, 2025 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 12, 2024 INPR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
May 21, 2024 NURC
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Apr 12, 2024 CORR
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 11, 2024 COC.
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 17, 2024 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 7, 2021 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Feb 27, 2021 NREP
FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 6, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 27, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Aug 7, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 22, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2020 NONP
WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
Jul 6, 2020 ISMR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2020 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2020 TROA
REFUSAL PROCESSED BY IB
Oct 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 16, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 16, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Sep 10, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 6, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 5, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 26, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 22, 2019 REPR